УНІГРІЛІН 75 / UNIGRILLIN 75

Przegląd produktu

About УНІГРІЛІН 75 / UNIGRILLIN 75

УНІГРІЛІН 75 / UNIGRILLIN 75 is a medication containing the active ingredient Eptifibatide, classified as Platelet Aggregation Inhibitor. Eptifibatide, is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. Eptifibatide is a cyclic heptapeptide derived from a disintegrin protein found in the venom of the southeastern pygmy rattlesnake. It belongs to the class of the arginine-glycine-aspartate-mimetics and reversibly binds to platelets.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Eptifibatide injection is a platelet aggregation inhibitor indicated for: Treatment of acute coronary syndrome (ACS) managed.
• Used for: 1) Treatment of patients undergoing PCI (including intracoronary stenting) (1
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Eptifibatide, the active ingredient in УНІГРІЛІН 75 / UNIGRILLIN 75, belongs to the Platelet Aggregation Inhibitor class. 1 INDICATIONS AND USAGE Eptifibatide injection is a platelet aggregation inhibitor indicated for: Treatment of acute coronary syndrome (ACS) managed medically or with percutaneous coronary intervention (PCI) (1. 1) Treatment of patients undergoing PCI (including intracoronary stenting) (1. 2) 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking УНІГРІЛІН 75 / UNIGRILLIN 75. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use УНІГРІЛІН 75 / UNIGRILLIN 75 for extended periods without medical advice.